FDA announced today the approval of Ervebo, the first FDA-approved vaccine for the prevention of Ebola virus disease (EVD), caused by Zaire ebolavirus in individuals 18 years of age and older.
Read more: First FDA-approved vaccine for the prevention of Ebola virus disease, marking a critical milestone in public health preparedness and response